十一月 2025
- Home
- PRA Health Sciences
十一月 2025的PRA Health Sciences市场份额分析
icon is the world's leading clinical research organisation,
providing outsourced clincal development and commercialisation
services to the pharmaceutical, biotechnology and medical
device
industries.
PRA Health Sciences(包含公司地区分支机构)
查看更多网站流量和参与度信息- prahs.com
PRA Health Sciences收入截至 十一月 2025为 > 1B
PRA Health Sciences主要域名产生的收入
3 年中PRA Health Sciences主要域名的收入
PRA Health Sciences主要域名的收入
PRA Health Sciences热门域名的总访问量
了解PRA Health Sciences市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
PRA Health Sciences热门域名的平均访问时长
分析PRA Health Sciences参与度指标。
过去 3 个月的平均访问时长
无数据可显示
无数据可显示
PRA Health Sciences热门域名的平均页面浏览量
了解PRA Health Sciences如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
PRA Health Sciences 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Maharishi Ayurveda Products International, Inc. partners with Prahs.It’s nearly a year since Mapi Group joined forces with PRA Health Sciences and as a company, Mapi Group has never been more diverse.
五月 24, 2022阅读更多
新闻Prahs launches vaccines and therapeutics for COVID-19.PRA Health Sciences has expanded its pharmacovigilance solutions to include a broader range of post-marketing services geared toward authorized vaccines and therapeutics for COVID-19.
五月 4, 2021阅读更多
新闻ICON plc acquired Prahs for $12B on Mar 3rd '21.Management's response to a potential period of consolidation as opposed to sector-leading growth has been to turn to M&A, however, as on Feb. 24 ICON announced that it would acquire competitor PRA Health Sciences ( PRAH ) in a $12bn deal, with PRA shareholders receiving $80 in cash and 0.4125 shares of ICON stock per share.
四月 3, 2021阅读更多
查看 PRA Health Sciences 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。